Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver
disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric …
disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric …
The gut–liver axis and the intersection with the microbiome
In the past decade, an exciting realization has been that diverse liver diseases—ranging
from nonalcoholic steatohepatitis, alcoholic steatohepatitis and cirrhosis to hepatocellular …
from nonalcoholic steatohepatitis, alcoholic steatohepatitis and cirrhosis to hepatocellular …
Sugar alcohols—their role in the modern world of sweeteners: a review
M Grembecka - European Food Research and Technology, 2015 - Springer
Epidemic obesity and diabetes encouraged the changes in population lifestyle and
consumers' food products awareness. Food industry has responded people's demand by …
consumers' food products awareness. Food industry has responded people's demand by …
Management of the critically ill patient with cirrhosis: a multidisciplinary perspective
Methods Prior to the conference, the organizing committee identified topics relevant to the
management of patients with ACLF. A diverse international panel representing multiple …
management of patients with ACLF. A diverse international panel representing multiple …
Rifaximin treatment in hepatic encephalopathy
Background Hepatic encephalopathy is a chronically debilitating complication of hepatic
cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the …
cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the …
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy
BC Sharma, P Sharma, MK Lunia… - Official journal of the …, 2013 - journals.lww.com
OBJECTIVES: Hepatic encephalopathy (HE) is associated with poor prognosis in cirrhosis.
Drugs used in the treatment of HE are primarily directed at the reduction of the blood …
Drugs used in the treatment of HE are primarily directed at the reduction of the blood …
Covert and overt hepatic encephalopathy: diagnosis and management
KR Patidar, JS Bajaj - Clinical Gastroenterology and Hepatology, 2015 - Elsevier
Hepatic encephalopathy (HE) is part of a spectrum of neurocognitive changes in cirrhosis.
HE is divided into 2 broad categories based on severity: covert hepatic encephalopathy …
HE is divided into 2 broad categories based on severity: covert hepatic encephalopathy …
[PDF][PDF] Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis
A Kumar, G Davuluri, RN Silva, MPKJ Engelen… - …, 2017 - Wiley Online Library
Sarcopenia or skeletal muscle loss is a frequent, potentially reversible complication in
cirrhosis that adversely affects clinical outcomes. Hyperammonemia is a consistent …
cirrhosis that adversely affects clinical outcomes. Hyperammonemia is a consistent …
[HTML][HTML] Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
H Fukui - World journal of hepatology, 2015 - ncbi.nlm.nih.gov
A “leaky gut” may be the cutting edge for the passage of toxins, antigens or bacteria into the
body, and may play a pathogenic role in advanced liver cirrhosis and its complications …
body, and may play a pathogenic role in advanced liver cirrhosis and its complications …
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with …
LL Gluud, H Vilstrup… - Cochrane Database of …, 2016 - cochranelibrary.com
Background Non‐absorbable disaccharides (lactulose and lactitol) are recommended as
first‐line treatment for hepatic encephalopathy. The previous (second) version of this review …
first‐line treatment for hepatic encephalopathy. The previous (second) version of this review …